ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner
13.1.2026 09:00:00 CET | news aktuell GmbH | Press Release
Zoetermeer, Netherlands - 13 January 2026 - Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
ORTEC, a global leader in supply chain planning and workforce management software, today announced the strategic acquisition of Klages & Partner, a German developer of clinical staff management software for hospitals, clinics, and care facilities meeting the complex demands of modern healthcare. Klages & Partner serves over 200 healthcare customers, primarily in Germany.
This acquisition supports ORTEC’s Workforce Management strategic objective to strengthen its position in the German healthcare sector, building on decades of experience and established leadership in workforce scheduling for the Dutch healthcare market, as well as an existing customer base across Belgium, Finland, Germany, the United Kingdom, and Australia. It expands ORTEC’s German industry-specific expertise while maintaining focus on delivering clarity, reliability, and human-centric technology across its solutions portfolio.
“Klages & Partner shares our commitment, quite simply, to making work work better for people in complex operational environments,” said Georgios Sarigiannidis, CEO of ORTEC. “Together, we can offer healthcare organizations even more powerful, user-friendly tools to plan, manage, and optimize their workforce, ultimately improving care delivery and staff satisfaction.”
Founded in 1991, Klages & Partner develops and distributes software designed hand-in-hand with healthcare professionals to address the unique challenges of clinical staff planning. Their solutions simplify complex workforce scheduling while ensuring fairness, efficiency, and compliance, enabling hospital and care facility teams to focus on the work that matters most: patient care.
ORTEC and Klages & Partner have a shared commitment to customer value, practical innovation, and building solutions that genuinely support healthcare professionals. ORTEC brings long-standing experience in workforce scheduling for healthcare organizations, while Klages & Partner contributes deep local market knowledge and trusted relationships within the German care sector.
The transaction closed at the end of December 2025.
About Klages & Partner
Klages & Partner develops and distributes clinical staff management software in close collaboration with hospital professionals. Serving more than 200 customers, primarily in Germany, the company’s mission is to make workforce planning in healthcare effective, fair, and sustainable.
Contacts
Rebecca NobleVice President Corporate CommunicationsORTEC BV
Media Contact
Images
About ORTEC
For more than 40 years ORTEC builds software for planning supply chains and managing workforces. We help organizations figure out the best way to use their people and resources, even when things change. Using our trusted, AI-powered technology dissolves noise and friction so people can stay in the flow. Our goal is simple: let our software provide confidence, fairness, and reliability, so everyone can focus on the work that truly matters. ORTEC is backed by Battery Ventures. Discover more at ortec.com.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
agineo expands partnership with ServiceNow, launches AI Control Tower as a Service20.10.2026 12:48:13 CEST | Press Release
New managed service provides transparency into the AI landscape and helps companies centrally manage AI, monitor risks and regulatory requirements, and highlight business benefits.
Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 09:23:41 CEST | Press Release
Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.
Elections will determine whether Israel remains the Middle East’s only democracy, new report says16.10.2026 12:00:50 CEST | Press Release
Los Angeles/DNA - For the first time since the Hamas attacks of three years ago, Israel is set to go to the polls on October 27 to elect the members of the 26th Knesset. In 2023 the country was in the top group of ‘consolidated democratic states’, according to the 2026 Berggruen Governance Index (BGI), just as it had been in 2000. However, according to a new report from governance experts, the wars unleashed on multiple fronts in rapid succession following the Hamas attacks launched from Gaza have changed Israel politically, economically, and socially. The report ‘Israeli Governance Performance: The 2026 Elections, Democracy and Future Scenarios’ was produced by researchers at the University of California, Los Angeles (UCLA), the Los Angeles-based Berggruen Institute, and Berlin’s Hertie School. The ongoing election campaign, which never stopped despite the longest war in Israel’s history, is about to conclude with voting at the ballot box, in what the entire population is experiencing
S&D Conference on Quality Jobs: Europe must protect workers through the digital transition16.10.2026 08:30:40 CEST | Press Release
Brussels – The Socialists and Democrats (S&D) Group in the European Parliament is stepping up political pressure for an ambitious European framework for quality jobs. At the “Quality Jobs for All” conference in Brussels on 14 October, the impact of artificial intelligence, digital surveillance, precarious employment conditions and growing work-related stress was at the centre of the debate. The conference took place as the European Commission is expected to present its proposal for a Quality Jobs Act in December 2026. Quality Jobs for All is one of the S&D Group’s six flagship political priorities, set out under their Strategic Turn initiative in recent months. Jobs and the labour markets are changing rapidly, with automation and artificial intelligence able to fundamentally change professions and their inherent activities. At the same time, concerns are growing about job cuts, wage pressure, social exclusion and the loss of workers’ voices at work. Experts at the conference have warne
Amid Mounting Global Health Crises, World Health Summit Closes in Berlin with New Commitments14.10.2026 14:13:51 CEST | Press Release
Berlin, October 14, 2026 - The World Health Summit 2026 concluded with new funding commitments, research findings, and initiatives. Under the theme “From Crisis to Resilience: Innovating for Health,” the Summit convened more than 4,000 on-site participants from 130 countries and territories, generated over 50,000 livestream views, and featured more than 400 speakers, including 20 ministers and state secretaries, across 76 sessions.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom